ArticleTranslational oncology2017

Corrigendum to "PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells [Translational Oncology 7 (2014) 256-266.e5].

Kumar Sanjiv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.